ASCO 2024 - Global Speaker Series: Dr. Judy-Anne Williams Chapman on Standardizing ER and PgR Quantitation in Breast Cancer

Dr. Judy-Anne Williams Chapman, PhD, emphasizes her four decades of work on the critical topic of estrogen and progesterone receptors. She proposes an adjunctive statistical standardization of quantitated ER and PgR to enhance inter-laboratory comparability of biomarker results and improve the therapeutic management of breast cancer.